Search Results - "Locher, Clara"

Refine Results
  1. 1

    A survey of biomedical journals to detect editorial bias and nepotistic behavior by Scanff, Alexandre, Naudet, Florian, Cristea, Ioana A, Moher, David, Bishop, Dorothy V M, Locher, Clara

    Published in PLoS biology (01-11-2021)
    “…Alongside the growing concerns regarding predatory journal growth, other questionable editorial practices have gained visibility recently. Among them, we…”
    Get full text
    Journal Article
  2. 2

    Data-sharing and re-analysis for main studies assessed by the European Medicines Agency-a cross-sectional study on European Public Assessment Reports by Siebert, Maximilian, Gaba, Jeanne, Renault, Alain, Laviolle, Bruno, Locher, Clara, Moher, David, Naudet, Florian

    Published in BMC medicine (20-05-2022)
    “…Transparency and reproducibility are expected to be normative practices in clinical trials used for decision-making on marketing authorisations for new…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    The dendritic cell–tumor cross-talk in cancer by Ma, Yuting, Aymeric, Laetitia, Locher, Clara, Kroemer, Guido, Zitvogel, Laurence

    Published in Current opinion in immunology (01-02-2011)
    “…The question as to whether the tumor grows because of or despite the host immune system is being progressively addressed with refined technology, gene…”
    Get full text
    Journal Article
  8. 8

    Reporting of interventional clinical trial results in an academic center: a survey of completed studies by Alix-Doucet, Anne Sophie, Vinatier, Constant, Fin, Loïc, Léna, Hervé, Rangé, Hélène, Locher, Clara, Naudet, Florian

    Published in BMC medical research methodology (22-04-2024)
    “…The dissemination of clinical trial results is an important scientific and ethical endeavour. This survey of completed interventional studies in a French…”
    Get full text
    Journal Article
  9. 9

    Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature by Caquelin, Laura, Gewily, Mohamed, Mottais, Wendy, Tebaldi, Chloé, Laviolle, Bruno, Naudet, Florian, Locher, Clara

    Published in BMC cancer (09-04-2022)
    “…Tivozanib (Fotivda) is an anti-angiogenic tyrosine kinase inhibitor that was denied access to the US market by the Food and Drug Administration (FDA). In…”
    Get full text
    Journal Article
  10. 10

    Chemotherapy and radiotherapy: Cryptic anticancer vaccines by Ma, Yuting, Kepp, Oliver, Ghiringhelli, François, Apetoh, Lionel, Aymeric, Laetitia, Locher, Clara, Tesniere, Antoine, Martins, Isabelle, Ly, André, Haynes, Nicole M, Smyth, Mark J, Kroemer, Guido, Zitvogel, Laurence

    Published in Seminars in immunology (01-06-2010)
    “…Abstract An attractive, yet hitherto unproven concept predicts that the promotion of tumor regression should elicit the host's immune response against residual…”
    Get full text
    Journal Article
  11. 11

    How to improve the immunogenicity of chemotherapy and radiotherapy by Ma, Yuting, Conforti, Rosa, Aymeric, Laetitia, Locher, Clara, Kepp, Oliver, Kroemer, Guido, Zitvogel, Laurence

    Published in Cancer and metastasis reviews (01-03-2011)
    “…Chemotherapy or radiotherapy could induce various tumor cell death modalities, releasing tumor-derived antigen as well as danger signals that could either be…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Upstream ORF affects MYCN translation depending on exon 1b alternative splicing by Besançon, Roger, Valsesia-Wittmann, Sandrine, Locher, Clara, Delloye-Bourgeois, Céline, Furhman, Lydie, Tutrone, Giovani, Bertrand, Christophe, Jallas, Anne-Catherine, Garin, Elisabeth, Puisieux, Alain

    Published in BMC cancer (17-12-2009)
    “…The MYCN gene is transcribed into two major mRNAs: one full-length (MYCN) and one exon 1b-spliced (MYCNDelta1b) mRNA. But nothing is known about their…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Replication of systematic reviews: is it to the benefit or detriment of methodological quality? by Chapelle, Céline, Ollier, Edouard, Bonjean, Paul, Locher, Clara, Zufferey, Paul Jacques, Cucherat, Michel, Laporte, Silvy

    Published in Journal of clinical epidemiology (01-10-2023)
    “…To perform an overview of the overlap of systematic reviews (SRs) assessing direct oral anticoagulants and characterize these reviews in terms of bias and…”
    Get full text
    Journal Article
  18. 18

    Crosstalk between ER stress and immunogenic cell death by Kepp, Oliver, Menger, Laurie, Vacchelli, Erika, Locher, Clara, Adjemian, Sandy, Yamazaki, Takahiro, Martins, Isabelle, Sukkurwala, Abdul Qader, Michaud, Michael, Senovilla, Laura, Galluzzi, Lorenzo, Kroemer, Guido, Zitvogel, Laurence

    Published in Cytokine & growth factor reviews (01-08-2013)
    “…Abstract Preclinical and clinical findings suggest that tumor-specific immune responses may be responsible – at least in part – for the clinical success of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Clinical trials during pandemics and beyond: time for a more efficient pharmacological strategy by Lemaitre, Florian, Locher, Clara, Verdier, Marie-Clémence, Naudet, Florian

    Published in Journal of antimicrobial chemotherapy (12-08-2021)
    “…Abstract During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, clinical trials on antiviral or symptomatic drugs have been…”
    Get full text
    Journal Article